Professor Amir Ghaemmaghami and Dr Vanessa Loczenski join Advisory Board

We are delighted to be able to welcome Professor Amir Ghaemmaghami and Dr Vannessa Loczenski as the newest members of the CDT Advisory Board.

Amir Ghaemmaghami is a Professor of Immunology & Immuno-bioengineering at the University of Nottingham. Over the years his group’s work in the area of innate immune recognition and allergic sensitization has led to many novel findings in the field. Their more recent multi-disciplinary activities in bioengineering and immune modulation through surface engineering are underpinned by major national and international initiatives.

In 2010 Vanessa Loczenski joined the EPSRC/AstraZeneca Centre for Doctoral Training in Targeted Therapeutics and Formulation Science at the School of Pharmacy in Nottingham. Vanessa successfully completed her doctorate in November 2014 and joined the Formulation Technology Group at Syngenta (Jealotts Hill) working as a RNA formulation technical specialist on several projects related to RNA interference.

Dr Vanessa Loczenski and Professor Amir Ghaemmaghami